Atara Biotherapeutics, Inc. Quarterly Costs and Expenses in USD from Q3 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2022 to Q3 2024.
  • Atara Biotherapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $61.9M, a 13.7% decline year-over-year.
  • Atara Biotherapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $232M.
  • Atara Biotherapeutics, Inc. annual Costs and Expenses for 2023 was $285M, a 17.3% decline from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $232M $61.9M -$9.8M -13.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $241M $46.9M -$25.5M -35.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $267M $58.6M -$17.6M -23.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $285M $64.2M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $71.8M -$17.3M -19.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $72.4M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $76.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $89.1M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.